The FDA has decided pharmaceutical manufacturers should put additional information on the labels of their hormone replacement therapies, warning women that taking them could increase their risk of developing dementia or Alzheimer's disease. The hormone replacements have been linked previously with increased risk of breast cancer, heart attacks and strokes, but now the FDA wants new warnings, citing studies showing long-term users over 64 had a higher risk of dementia.

Related Summaries